RJA
CAH icon

Raymond James & Associates’s Cardinal Health CAH Stock Holding History

Raymond James & Associates’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-50,100
Closed -$5K – 3252
2016
Q3 		$5K Buy
50,100
+1,700
+4% +$137K ﹤0.01% 3188
2016
Q2 		$19K Buy
48,400
+6,200
+15% +$494K ﹤0.01% 2938
2016
Q1 		$11K Buy
+42,200
New +$3.43M ﹤0.01% 2884

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James & Associates's CAH Position: Q3 2024 in Review

Raymond James & Associates increased its Cardinal Health (CAH) stake by 7.4% in Q3 2024, buying an estimated $2.24M and bringing the position to 309,960 shares worth $34.3M. The position accounts for 0.02% of the portfolio, ranked #574.

Raymond James & Associates first reported a position in CAH in Q2 2013 and has held it in 46 quarters since. The position peaked at $85.9M in Q3 2016. 1,016 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

  • Raymond James & Associates held 309,960 shares of Cardinal Health worth $34.3M as of Q3 2024.
  • Raymond James & Associates bought 21,414 Cardinal Health shares in Q3 2024, an estimated $2.24M.
  • Cardinal Health made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #574 holding.
  • Raymond James & Associates first reported a position in Cardinal Health in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Cardinal Health position peaked at $85.9M in Q3 2016.
  • 1,016 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.